CODI-PA — Compass Diversified

Summary of Compass Diversified's Q4 2025 Earnings Call

1. Key Financial Results and Metrics

• Q4 2025 GAAP Net Revenue: $468.6 million, down 5.1% year-over-year, primarily due to the impact of Lugano's deconsolidation.
• Q4 2025 GAAP Net Loss: $78.8 million, including over $25 million in one-time costs related to Lugano.
• Full Year 2025 Net Revenues: $1.9 billion, up 4.8%.
• Full Year 2025 GAAP Net Loss: $293.7 million, including approximately $60 million in investigation and restatement costs.
• Non-GAAP Results (excluding Lugano):
  • Full Year Net Sales: $1.8 billion, up 3.9%.
  • Subsidiary Adjusted EBITDA: $345.8 million, an increase of 8.8%.
  • Consumer Adjusted EBITDA: Up 13.8%; Industrial Adjusted EBITDA: Up 1.1%.
• Cash Position: $68 million in cash and cash equivalents, with $96 million available on the revolver.
• Leverage Ratio: Approximately 5.47x at year-end, slightly higher than anticipated.

2. Strategic Updates and Business Highlights

• Operational Resilience: Despite challenges, CODI's subsidiaries showed strength, with mid-single-digit revenue growth and high single-digit adjusted EBITDA growth (excluding Lugano).
• Focus on Deleveraging: CODI aims to reduce its leverage ratio through organic growth and attractive divestitures.
• Sale Processes: Multiple sale processes for subsidiaries are underway, with strong interest from both financial and strategic buyers.
• Subsidiary Performance:
  • BOA: Strong performance at the Winter Games, expected to grow further.
  • The Honey Pot: Established a leading position in feminine care, with significant growth potential.
  • Arnold: Ended the year with a backlog over 40% higher than the previous year, positioned well for growth in aerospace and defense despite geopolitical headwinds.
  • Altor: Facing challenges due to vaccine sales decline and tariffs affecting appliance purchases.

3. Forward Guidance and Outlook

• 2026 Subsidiary Adjusted EBITDA Guidance: Expected to be between $345 million to $395 million, with consumer adjusted EBITDA between $220 million to $260 million and industrial adjusted EBITDA between $125 million to $135 million.
• CapEx for 2026: Anticipated between $30 million to $40 million.
• Free Cash Flow: Expected to be between $50 million to $100 million, with potential upside from recoveries related to Lugano.

4. Bad News, Challenges, or Points of Concern

• Impact of Lugano: The bankruptcy and related costs have significantly affected financial results.
• Geopolitical Risks: Ongoing export restrictions from China and tariff uncertainties are creating operational challenges, particularly for Arnold and Altor.
• Consumer Spending Pressures: Tariffs and inflation are negatively impacting consumer demand, particularly in the apparel sector for 5.11.
• Wider Guidance Range: The uncertainty in the macroeconomic environment has led to a wider than normal range in guidance for 2026.

5. Notable Q&A Insights

• Sale Processes: Strong interest in subsidiaries, with multiple bidders expected. The timeline for potential transactions is approximately 6 months.
• Industrial Business Outlook: Arnold is expected to experience growth in the latter half of 2026, while Altor's outlook remains cautious due to ongoing challenges.
• 5.11 Performance: The professional side is stable, but the consumer side is facing headwinds due to inflation and tariff impacts.
• Leverage Targets: Long-term target of 3x to 3.5x leverage, with a goal of reaching around 4x by the end of 2026 through a combination of organic growth and potential asset sales.

Overall, while CODI faced significant challenges in 2025, the company is focused on strategic initiatives to improve its financial position and operational performance moving into 2026.